Vonoprazan Promising for Erosive Esophagitis

The oral potassium-competitive acid blocker vonoprazan was noninferior and superior to the proton pump inhibitor lansoprazole for erosive esophagitis in a phase 3 trial.
Medscape Medical News

source https://www.medscape.com/viewarticle/982598?src=rss